Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma.
Marta Di SimoneAnna Maria CorsaleFrancesca ToiaMojtaba Shekarkar AzgomiAnna Barbara Di StefanoElena Lo PrestiAdriana CordovaLuigi MontesanoFrancesco DieliSerena MeravigliaPublished in: Journal of leukocyte biology (2024)
Melanoma is one of the most sensitive tumors to immune modulation and the major challenge for melanoma patients' survival is immune checkpoint inhibitors therapy. γδ T lymphocytes play an antitumoral role in a broad variety of tumors including melanoma and they are optimal candidates for cellular immunotherapy. Thus, a comprehensive analysis of the correlation between γδ T cells and immune checkpoint receptors in the context of melanoma was conducted, with the aim of devising an innovative combined immunotherapeutic strategy. In this study, using the GEPIA2.0 database, a significant positive correlation was observed between the expression of γδ T cell-related genes (TRGC1, TRGC2, TCRD) and immune checkpoint genes (PDCD1, HAVCR2, LAG3), highlighting the potential role of γδ T cells in the immune response within melanoma. Moreover, flow cytometry analysis unveiled a significant augmentation in the population of γδ T cells within melanoma lesions, which exhibited the expression of immune checkpoint receptors including LAG3, TIM-3, and PD1. Analysis of scRNA seq data revealed a significant enrichment and functional reprogramming of γδ T cell clusters in response to immune checkpoint inhibitors (ICI). Interestingly, the effects of ICI therapy varied between Vδ1 and Vδ2 γδ T cell subsets, with distinct changes in gene expression patterns. Lastly, a correlation analysis between γδ T cell abundance, immune checkpoint gene expression, and clinical outcomes in melanoma patients showed that low expression of immune checkpoint genes, including LAG3, HAVCR2, and PDCD1, was associated with improved 1-year overall survival, emphasizing the significance of these genes in predicting patient outcomes, potentially outweighing the impact of γδ T cell abundance. This study offers critical insights into the dynamic interaction between γδ T cells, immune checkpoint receptors, and melanoma, providing valuable prospectives for potential therapeutic avenues and predictive markers in this intricate interplay.
Keyphrases
- gene expression
- skin cancer
- immune response
- poor prognosis
- genome wide
- ejection fraction
- dna methylation
- flow cytometry
- basal cell carcinoma
- single cell
- risk assessment
- stem cells
- bone marrow
- emergency department
- inflammatory response
- toll like receptor
- genome wide identification
- patient reported outcomes
- transcription factor
- soft tissue
- electronic health record
- patient reported
- adverse drug